Localization and mobility of glucose-coated gold nanoparticles within the brain.

Autor: Gromnicova R; Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UK., Yilmaz CU; Department of Laboratory Animal Science, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey., Orhan N; Department of Neuroscience, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey., Kaya M; Department of Physiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Davies H; Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UK., Williams P; Midatech Pharma Plc, Abingdon, UK., Romero IA; Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UK., Sharrack B; Department of Neurology, University of Sheffield, Sheffield, UK., Male D; Department of Life, Health & Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UK.
Jazyk: angličtina
Zdroj: Nanomedicine (London, England) [Nanomedicine (Lond)] 2016 Mar; Vol. 11 (6), pp. 617-25. Date of Electronic Publication: 2016 Feb 25.
DOI: 10.2217/nnm.15.215
Abstrakt: Aim: To identify the localization of glucose-coated gold nanoparticles within cells of the brain after intravascular infusion which may point to the mechanism by which they cross the blood-brain barrier.
Materials & Methods: Tissue distribution of the nanoparticles was measured by inductively-coupled-mass spectrometry and localization within the brain by histochemistry and electron microscopy.
Results & Conclusion: Nanoparticles were identified within neurons and glial cells more than 10 μm from the nearest microvessel within 10 min of intracarotid infusion. Their distribution indicated movement across the endothelial cytosol, and direct transfer between cells of the brain. The rapid movement of this class of nanoparticle (<5 nm) into the brain demonstrates their potential to carry therapeutic biomolecules or imaging reagents.
Databáze: MEDLINE